Insider Transactions in Q2 2021 at Gilead Sciences, Inc. (GILD)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2021
|
Javier Rodriguez Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,838
+50.0%
|
-
|
|
Jun 10
2021
|
Andrew D Dickinson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,605
-4.16%
|
$110,745
$69.29 P/Share
|
|
Jun 10
2021
|
Andrew D Dickinson Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,646
+8.64%
|
-
|
|
May 06
2021
|
Harish Manwani Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,936
+25.51%
|
-
|
|
May 06
2021
|
Richard James Whitley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,936
+5.53%
|
-
|
|
May 06
2021
|
Jacqueline K Barton Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,936
+10.99%
|
-
|
|
May 06
2021
|
Olsen Per Wold Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,936
+1.86%
|
-
|
|
May 04
2021
|
Johanna Mercier Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
19,496
-70.73%
|
$1,286,736
$66.09 P/Share
|
|
May 03
2021
|
Richard James Whitley Director |
SELL
Open market or private sale
|
Direct |
20,282
-39.46%
|
$1,298,048
$64.57 P/Share
|
|
May 03
2021
|
Richard James Whitley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,282
+28.29%
|
$405,640
$20.64 P/Share
|